NCT05542914

Brief Summary

Men who have sex with men (MSM) are disproportionally affected by HIV and substance abuse in the U.S., Europe, and Latin America. However, as in the general population, identifying and engaging MSM with problematic substance use (PSU) into treatment is a significant challenge, which results in the great majority of MSM with PSU never receiving treatment. The proposed study seeks to develop and pilot an electronic-Screening, Brief Intervention, Referral to Treatment (e-SBI-RT)program tailored for MSM awaiting their HIV test at Nexo Asociacion Civil, our community partners in Buenos Aires. The tablet-based e-SBI will integrate substance use and sexual risk behavior screeners and individually tailored Motivational Interviewing (MI) as the BI. We will also adapt and pilot the implementation of the Young Men's Health Project (from YMHP to MHP) a four-session MI-based intervention that effectively reduced substance use and condomless anal intercourse among substance using MSM. The Specific Aims of this R34 study are to: 1) develop the e-SBI intervention for MSM in an HIV testing context to reduce substance use and HIV risk behavior (Primary); 2) assess the feasibility and acceptability of integrating e-SBI into the HIV testing process at Nexo; and 3) assess the feasibility and acceptability of implementing adapted YMHP at Nexo. In Stage 1 (Development) we will develop e-SBI, adapt YMHP into MHP, train MHP counselors, and pilot e-SBI with 50 MSM coming to Nexo for HIV testing. In Stage 2 (RCT Pilot), we will randomize 200 MSM coming to Nexo for HIV testing at a 3:1 ratio (eSBI: Screening Assessments Only-SA) to assess the feasibility and acceptability of e-SBI among MSM coming to Nexo for HIV testing and establish and pilot the RCT process for a future trial. As a secondary aim, we will assess uptake, acceptability, and feasibility of delivering MHP to participants with low or moderate risk substance use and subsequent referrals to substance abuse treatment among participants with high-risk substance use or dependence. Lastly, we will explore preliminary findings on substance use and sexual risk reduction outcomes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
196

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 16, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2025

Completed
Last Updated

June 27, 2025

Status Verified

June 1, 2025

Enrollment Period

2.4 years

First QC Date

September 6, 2022

Last Update Submit

June 24, 2025

Conditions

Keywords

SBIRTHIV PreventionMSM

Outcome Measures

Primary Outcomes (3)

  • Recruitment Rate: Percent of MSM testing clients at Nexo who accept entry into the study

    Will tabulate the percentage of MSM testing clients at Nexo who accept entry into the study vs those who refuse entry

    8 months

  • Retention Rate: percent of participants who complete e-SBI

    Will calculate the percent of participants who fully complete the e-SBI vs participants who do not complete the intervention

    6 months

  • Mean overall acceptability rating of e-SBI from the TFA questionnaire

    Will use the last question on the TFA questionnaire "Overall, how acceptable is the e-SBI to you?" to calculate mean overall acceptability and percent of participants who rate acceptability at 4 or higher.

    6 months

Secondary Outcomes (4)

  • the percent of MSM with moderate or high-risk substance use who enter MHP from either RCT condition

    6 months

  • the percent of MHP participants who complete all four sessions

    6 months

  • Mean overall acceptability rating of MHP from the TFA questionnaire

    6 months

  • percentage of sessions conducted by each MHP counselor that meet criteria for MI proficiency

    6 months

Other Outcomes (3)

  • Occasions of drug use during the past month

    30 days

  • Occasions of heavy alcohol consumption (5+ drinks) during the past month

    30 days

  • Occasions of anal intercourse during the past month with a partner who is HIV positive or of unknown serostatus .

    30 days

Study Arms (2)

e-SBI

EXPERIMENTAL

Electronic Screening and Brief Intervention for substance use and HIV risk reduction

Behavioral: electronic screening and brief intervention.Behavioral: Men's Health Project (MHP)

Assessment Only

ACTIVE COMPARATOR

These individuals complete only the screening instruments, no brief intervention

Behavioral: electronic screening and brief intervention.Behavioral: Men's Health Project (MHP)

Interventions

e-SBIs is an evidence based approach to engage non-treatment-seeking individuals who use substances to reduce use or enter treatment. It consists of completing screening instruments related to substance use and sexual risk behavior and receiving a tablet-based, Motivational Interviewing intervention to help individuals build motivation to reduce their use and plans to achieve their substance use and HIV risk reduction goals.

Assessment Onlye-SBI

This intervention will be offered to participants with moderate or greater severity substance use. This is a 4-session Motivational interviewing based intervention that has shown efficacy in prior studies. We are providing this as a possible referral program for study participants (either arm) who are interested in receiving substance abuse intervention.

Assessment Onlye-SBI

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsIdentifies as male or cis-gender male
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants in Stage 1 Focus Groups (FGs) and in-depth interviews (IDIs):
  • Man who has had sex with men in the past 6 months;
  • years of age or older;
  • Recently sought an HIV test at Nexo;
  • Reports using drugs least once per month in the past 6 months and/or score 4 or greater on the AUDIT C, suggesting moderate risk alcohol use.
  • Participants in Stage 1 e-SBI pilot and the Stage 2 RCT:
  • Man who has had sex with men in the past 6 months
  • years of age or older;
  • Currently seeking an HIV test at Nexo
  • \. Score of moderate or high risk drug or alcohol use based on the ASSIST and AUDIT, respectively

You may not qualify if:

  • be in need of acute detoxification, as demonstrated by physical withdrawal symptoms or a history of withdrawal, such as previous delirium tremens or seizures
  • reported regular use of opioids
  • enrolled in concurrent drug- or alcohol-related treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nexo Asociacion Civil

Buenos Aires, C1022AAD, Argentina

Location

Related Publications (1)

  • Balan IC, Marone RO, Barreda V, Naar S, Wang Y. Integration of an Electronic Screening, Brief Intervention, and Referral to Treatment Program Into an HIV Testing Program to Reduce Substance Use and HIV Risk Behavior Among Men Who Have Sex With Men: Protocol for Intervention Development and a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2024 Mar 14;13:e56683. doi: 10.2196/56683.

MeSH Terms

Conditions

Substance-Related Disorders

Interventions

Crisis Intervention

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Ivan C Balan

    Florida State University, College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Professor

Study Record Dates

First Submitted

September 6, 2022

First Posted

September 16, 2022

Study Start

November 1, 2022

Primary Completion

March 15, 2025

Study Completion

March 15, 2025

Last Updated

June 27, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

We will compile structured de-identified datasets and can make them available for additional/secondary data analyses. The research team will follow the "standards for privacy of individually identifiable health information." Participants' records and results will not be identified. No contact information will be included in any archived datasets. To preclude indirect identification, certain data elements such as date of birth will be transformed; date of birth will be used to provide a categorical age variable.

Time Frame
Starting 6 months after publication of main study findings.
Access Criteria
We will collaborate with and make our data available to other researchers for additional/secondary analyses. Dr. Balán and the research team will develop a process to review and approve data release based on concept sheets submitted by interested investigators and whether the data request is for new lines of analysis. Formal data sharing agreements will be developed to guide and encourage further data mining of the proposed datasets for various purposes

Locations